Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...

Imaging Studies for Cardiovascular System IV: CMRI

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An international 20 country patient and physician survey of the usability and acceptability of Stepped Care pathway in Parkinson's disease.

Scientific reports·2025

Same author

Quantification of plasma APOE4 with a novel automated Lumipulse immunoassay enables the identification of homozygous and heterozygous APOE ε4 carrier status.

Clinica chimica acta; international journal of clinical chemistry·2025

Same author

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease.

Nature·2025

Same author

Optical coherence tomography reveals retinal structural abnormalities in α-synucleinopathies: insights from the Padua-CESNE cohort.

Journal of neural transmission (Vienna, Austria : 1996)·2025

Same author

The role of opicapone in the management of Parkinson's disease: an Italian consensus through a combined Nominal Group Technique and Delphi approach.

European review for medical and pharmacological sciences·2023

Same author

Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson's disease patients: an European multicentre survey.

Journal of neural transmission (Vienna, Austria : 1996)·2020

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Reproducibility of regional metabolic covariance patterns: comparison of four populations.

J R Moeller¹, T Nakamura, M J Mentis

¹Department of Psychiatry, Columbia College of Physicians and Surgeons, New York, New York, USA.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine

|August 18, 1999

Summary

This summary is machine-generated.

This study shows that a specific brain metabolic pattern identified using [18F]fluorodeoxyglucose (FDG) PET is reproducible and can accurately diagnose Parkinson's disease (PD) in diverse patient groups.

More Related Videos

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Published on: June 7, 2024

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[¹⁸F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level

Published on: January 24, 2025

Related Experiment Videos

Last Updated: Jun 18, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Published on: June 7, 2024

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[¹⁸F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level

Published on: January 24, 2025

Area of Science:

Neuroscience
Medical Imaging
Biomarkers

Background:

Parkinson's disease (PD) diagnosis relies on clinical symptoms, lacking definitive biomarkers.
Previous [18F]fluorodeoxyglucose (FDG) PET network analysis identified a unique metabolic covariation pattern distinguishing PD patients from healthy individuals.
Reproducibility of this pattern across different populations and imaging centers is crucial for its clinical utility.

Purpose of the Study:

To assess the reproducibility of a previously identified Parkinson's disease-related metabolic pattern (PDRP).
To evaluate the PDRP's potential as a diagnostic marker for PD across independent cohorts.
To validate the PDRP's discriminative ability using prospectively computed subject scores.

Main Methods:

Analysis of regional metabolic data from four independent Parkinson's disease (PD) cohorts (Groups A, B, C, D) using [18F]fluorodeoxyglucose (FDG) PET.
Correlation of the PDRP topography from the original cohort (Group A) with patterns from other cohorts.
Prospective computation of PDRP scores for all subjects and comparison between PD patients and healthy controls (N).

Main Results:

The PDRP topography demonstrated high correlation across all studied populations (r² ≈ 0.60, P < 0.0001).
Prospectively computed PDRP scores significantly discriminated PD patients from healthy controls in each cohort (P < 0.004).
The findings were consistent across different PET tomograph resolutions.

Conclusions:

The identified PDRP is highly reproducible across diverse patient populations and PET scanners.
PDRP scores derived from FDG PET imaging serve as a robust and accurate method for discriminating PD patients from controls.
Brain network imaging using FDG PET offers a promising approach for developing reliable metabolic markers for Parkinson's disease diagnosis.